3YV Stock Chart & Stats
€12.80
€0.00(0.00%)
At close: 4:00 PM EST
€12.80
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€9.55 - €15.70
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€429.82M
Enterprise Value€68.23B
Total Cash (Recent Filing)€12.04B
Total Debt (Recent Filing)€18.83B
Price to Earnings (P/E)39.7
Beta0.38
Next Earnings
Nov 12, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)60.12
Shares Outstanding31,808,600
10 Day Avg. Volume1
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)5.08
Price to Sales (P/S)2.04
P/FCF Ratio22.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.46
Revenue Forecast (FY)€263.54M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe substantial expansion in revenue over several years indicates meaningful growth in the company’s business base and customer activity. Continued top-line progress provides operating scale, supports reinvestment, and strengthens the foundation for future earnings improvement if profitability stabilizes.
Healthy Gross MarginA gross margin near 63% demonstrates that the company retains considerable value after direct costs, giving it resources to fund product development, sales investment, and operating infrastructure. This underlying economics can support durable growth even though recent bottom-line profitability weakened.
Positive Cash GenerationPositive operating and free cash flow shows that reported earnings are generally translating into cash rather than remaining purely accounting-based. Strong conversion improves the company’s ability to finance investment, meet obligations, and build resilience without relying entirely on external funding.
Bears Say
Sharp Margin CompressionThe steep deterioration in net margin shows that strong revenue growth is currently producing substantially less bottom-line profit. Unless operating profitability recovers, the company may have less capacity to reinvest, absorb cost increases, or convert market expansion into durable shareholder earnings.
Higher LeverageThe material increase in debt relative to equity reduces the balance-sheet cushion supporting the business and raises its financial risk profile. Greater leverage can constrain capital allocation, increase sensitivity to weaker earnings, and make future growth more dependent on maintaining adequate cash generation.
Cash Flow VolatilityAlthough cash generation is currently positive, the prior free-cash-flow decline and modest conversion relative to operating profit indicate that cash performance has not been consistently stable. Volatility or working-capital and investment swings could limit the predictability of internally funded growth.
Medley News
3YV FAQ
What was Medley, Inc.’s price range in the past 12 months?
Medley, Inc. lowest stock price was €9.55 and its highest was €15.70 in the past 12 months.
What is Medley, Inc.’s market cap?
Medley, Inc.’s market cap is €429.82M.
When is Medley, Inc.’s upcoming earnings report date?
Medley, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 11 days.
How were Medley, Inc.’s earnings last quarter?
Medley, Inc. released its earnings results on Aug 13, 2026. The company reported €0.292 earnings per share for the quarter, beating the consensus estimate of €0.261 by €0.031.
Is Medley, Inc. overvalued?
According to Wall Street analysts Medley, Inc.’s price is currently Overvalued.
Does Medley, Inc. pay dividends?
Medley, Inc. does not currently pay dividends.
What is Medley, Inc.’s EPS estimate?
Medley, Inc.’s EPS estimate is 0.04.
How many shares outstanding does Medley, Inc. have?
Medley, Inc. has 31,808,600 shares outstanding.
What happened to Medley, Inc.’s price movement after its last earnings report?
Medley, Inc. reported an EPS of €0.292 in its last earnings report, beating expectations of €0.261. Following the earnings report the stock price went up 1.739%.
Which hedge fund is a major shareholder of Medley, Inc.?
Currently, no hedge funds are holding shares in DE:3YV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medley, Inc.
Medley, Inc., a company based in Japan, develops and manages digital platforms for both the recruitment and medical industries. Its operations are structured into three primary segments: HR Platform Business, Medical Platform Business, and New Services. The firm's portfolio of offerings includes JobMedley, a human resources recruitment system specifically for medical, healthcare, and related sectors; CLINICS Telemedicine, a system enabling virtual consultations between patients and healthcare providers; CLINICS, a cloud-based platform for medical facility support; Pharms, which provides support systems for pharmacy front-desk operations; MEDLEY, a service offering medical information to patients; and Kaigo-no Honne, an online portal for searching nursing care facilities. Additionally, Medley, Inc. undertakes proof-of-concept testing for its Pharms solutions. The company was established in 2009 and maintains its corporate headquarters in Tokyo, Japan.